STAAR Surgical Company cash flow to debt ratio of -89.25% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

STAAR Surgical Company has insufficient data to evaluate this check.

STAAR Surgical Company's debt to equity ratio is 0.11, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

STAAR Surgical Company has insufficient data to evaluate this check.

STAAR Surgical Company has negative EBITDA, making leverage ratio unreliable

STAAR Surgical Company earns at least as much interest as it pays. Interest obligations are fully covered.

STAAR Surgical Company's profit margin has decreased (12.50%) in the last year from -6.44% to -7.24%, signaling decreasing performance

STAAR Surgical Company's short-term assets of $311.55M exceed its short-term liabilities of $68.50M

STAAR Surgical Company's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

STAAR Surgical Company's return on equity of -6.07%, is lower than 15.00%, indicating bad performance

STAAR Surgical Company's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

STAAR Surgical Company had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings

STAAR Surgical Company has negative free cash flow, indicating the company is burning cash rather than generating it

STAAR Surgical Company has negative free cash flow, indicating cash burn

STAAR Surgical Company's yearly earnings has decreased 298.10% since last year from $-20.21M to $-80.45M, signaling decreasing performance

STAAR Surgical Company has insufficient data to evaluate this check.

ROIC -1.26% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

STAAR Surgical Company's 3-year revenue CAGR of -5.57% is negative, indicating declining revenue over the past 3 years

STAAR Surgical Company had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

STAAR Surgical Company had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity

STAAR Surgical Company has insufficient data to evaluate this check.

STAAR Surgical Company has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

STAAR Surgical Company is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

STAAR Surgical Company has negative or missing EBITDA, making EV/EBITDA ratio unreliable

STAAR Surgical Company is overvalued relative to its fair value price of 3.66 based on Earnings Fair Value model

STAAR Surgical Company has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

STAAR Surgical Company has a price-to-book ratio of 3.87x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

STAAR Surgical Company has a price-to-sales ratio of 4.70x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue